{"title":"CD4+ T细胞计数降低导致HIV感染者B细胞库异常改变。","authors":"Lina Huang , Xiangyu Zhang , Yu Shi , Rishen Liang , Qianqian Chen , Jing Yang , Xiaoni Zhang , Anning Fang , Qian Zhang , Chengchao Ding , Jiabin Wu , Jianjun Wu , Yong Gao","doi":"10.1016/j.antiviral.2025.106236","DOIUrl":null,"url":null,"abstract":"<div><div>Understanding the evolution of broadly neutralizing antibody (bNAb) activity in people living with HIV is crucial for vaccine design and immunization strategies. It has been proposed that antibody cross-reactive activity is associated with lower CD4<sup>+</sup> T cell counts during people living with HIV, but the underlying mechanisms remain unclear. To further explore the correlation between antibody reactivity and CD4<sup>+</sup> T cell counts, we recruited people living with HIV with varying CD4<sup>+</sup> T cell counts: (i) CD4<sup>+</sup> T cell ≤50 cells/μL, (ii) 50 cells/μL < CD4<sup>+</sup> T cell ≤200 cells/μL, (iii) 200 cells/μL < CD4<sup>+</sup> T cell ≤500 cells/μL, (iv) 500 cells/μL < CD4<sup>+</sup> T cell. We assessed the antigen-specific antibodies in serum using SOSIP.664 trimers from four different subtypes. Immune repertoire sequencing was used to characterize the B cell receptor (BCR) repertoire of these individuals. The evaluation of antigen-specific antibodies with different SOSIP.664 trimers showed enhanced reactivity in individuals with low CD4<sup>+</sup> T cell counts compared to those with high/normal CD4<sup>+</sup> T cell counts. Analysis of antibody gene repertoires through BCR high throughput sequencing revealed an increased proportion of IgG with heavy chain complementarity-determining region 3 (CDRH3) loops exceeding 20 amino acids in individuals with CD4<sup>+</sup> T cell counts below 50 cells/μL. Notably, the IGHV1-46 and IGHV4-34 germlines, which are suggestive of most polyreactive B cells, were preferentially used in individuals with low CD4<sup>+</sup> T cell counts. These results suggest that limited engagement of CD4<sup>+</sup> T cells could facilitate the survival of aberrant B cell repertoire with long CDRH3 regions.</div></div>","PeriodicalId":8259,"journal":{"name":"Antiviral research","volume":"241 ","pages":"Article 106236"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV\",\"authors\":\"Lina Huang , Xiangyu Zhang , Yu Shi , Rishen Liang , Qianqian Chen , Jing Yang , Xiaoni Zhang , Anning Fang , Qian Zhang , Chengchao Ding , Jiabin Wu , Jianjun Wu , Yong Gao\",\"doi\":\"10.1016/j.antiviral.2025.106236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Understanding the evolution of broadly neutralizing antibody (bNAb) activity in people living with HIV is crucial for vaccine design and immunization strategies. It has been proposed that antibody cross-reactive activity is associated with lower CD4<sup>+</sup> T cell counts during people living with HIV, but the underlying mechanisms remain unclear. To further explore the correlation between antibody reactivity and CD4<sup>+</sup> T cell counts, we recruited people living with HIV with varying CD4<sup>+</sup> T cell counts: (i) CD4<sup>+</sup> T cell ≤50 cells/μL, (ii) 50 cells/μL < CD4<sup>+</sup> T cell ≤200 cells/μL, (iii) 200 cells/μL < CD4<sup>+</sup> T cell ≤500 cells/μL, (iv) 500 cells/μL < CD4<sup>+</sup> T cell. We assessed the antigen-specific antibodies in serum using SOSIP.664 trimers from four different subtypes. Immune repertoire sequencing was used to characterize the B cell receptor (BCR) repertoire of these individuals. The evaluation of antigen-specific antibodies with different SOSIP.664 trimers showed enhanced reactivity in individuals with low CD4<sup>+</sup> T cell counts compared to those with high/normal CD4<sup>+</sup> T cell counts. Analysis of antibody gene repertoires through BCR high throughput sequencing revealed an increased proportion of IgG with heavy chain complementarity-determining region 3 (CDRH3) loops exceeding 20 amino acids in individuals with CD4<sup>+</sup> T cell counts below 50 cells/μL. Notably, the IGHV1-46 and IGHV4-34 germlines, which are suggestive of most polyreactive B cells, were preferentially used in individuals with low CD4<sup>+</sup> T cell counts. These results suggest that limited engagement of CD4<sup>+</sup> T cells could facilitate the survival of aberrant B cell repertoire with long CDRH3 regions.</div></div>\",\"PeriodicalId\":8259,\"journal\":{\"name\":\"Antiviral research\",\"volume\":\"241 \",\"pages\":\"Article 106236\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antiviral research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0166354225001627\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0166354225001627","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV
Understanding the evolution of broadly neutralizing antibody (bNAb) activity in people living with HIV is crucial for vaccine design and immunization strategies. It has been proposed that antibody cross-reactive activity is associated with lower CD4+ T cell counts during people living with HIV, but the underlying mechanisms remain unclear. To further explore the correlation between antibody reactivity and CD4+ T cell counts, we recruited people living with HIV with varying CD4+ T cell counts: (i) CD4+ T cell ≤50 cells/μL, (ii) 50 cells/μL < CD4+ T cell ≤200 cells/μL, (iii) 200 cells/μL < CD4+ T cell ≤500 cells/μL, (iv) 500 cells/μL < CD4+ T cell. We assessed the antigen-specific antibodies in serum using SOSIP.664 trimers from four different subtypes. Immune repertoire sequencing was used to characterize the B cell receptor (BCR) repertoire of these individuals. The evaluation of antigen-specific antibodies with different SOSIP.664 trimers showed enhanced reactivity in individuals with low CD4+ T cell counts compared to those with high/normal CD4+ T cell counts. Analysis of antibody gene repertoires through BCR high throughput sequencing revealed an increased proportion of IgG with heavy chain complementarity-determining region 3 (CDRH3) loops exceeding 20 amino acids in individuals with CD4+ T cell counts below 50 cells/μL. Notably, the IGHV1-46 and IGHV4-34 germlines, which are suggestive of most polyreactive B cells, were preferentially used in individuals with low CD4+ T cell counts. These results suggest that limited engagement of CD4+ T cells could facilitate the survival of aberrant B cell repertoire with long CDRH3 regions.
期刊介绍:
Antiviral Research is a journal that focuses on various aspects of controlling viral infections in both humans and animals. It is a platform for publishing research reports, short communications, review articles, and commentaries. The journal covers a wide range of topics including antiviral drugs, antibodies, and host-response modifiers. These topics encompass their synthesis, in vitro and in vivo testing, as well as mechanisms of action. Additionally, the journal also publishes studies on the development of new or improved vaccines against viral infections in humans. It delves into assessing the safety of drugs and vaccines, tracking the evolution of drug or vaccine-resistant viruses, and developing effective countermeasures. Another area of interest includes the identification and validation of new drug targets. The journal further explores laboratory animal models of viral diseases, investigates the pathogenesis of viral diseases, and examines the mechanisms by which viruses avoid host immune responses.